武汉新茶网址：British media： Oxford University’s new crown vaccine project has made good progress
British media: Oxford University’s new crown vaccine project has made good progress
London, October 26 (Reporter Zhang Jiawei) According to a report by the British Broadcasting Corporation on the 26th,A new crown vaccine development project jointly developed by Oxford University and AstraZeneca Pharmaceuticals in the United Kingdom has made good progress.Candidate vaccines can induce “similar” immune responses in both older and younger adults.And older adults are less likely to have side effects after vaccination.
The BBC quoted a spokesperson from AstraZeneca Pharmaceuticals as saying,This progress is “inspiring”,And related results provide more evidence to support the safety and immunogenicity of candidate vaccines.
The report said,This phased progress comes from the Phase 2 clinical trial of this candidate vaccine.Whether it is effective in the end needs to be verified by phase 3 clinical trials.
This candidate new crown vaccine was developed by a team such as the Jenner Institute of Oxford University.The vaccine clinical trial was launched in late April this year,Then reached an agreement with AstraZeneca Pharmaceuticals,In-depth cooperation in the global development, production and distribution of this candidate vaccine.
This vaccine project has encountered some problems before: In early September,As a British volunteer had an adverse reaction after being vaccinated,Oxford University and AstraZeneca issued a statement saying,Suspend all vaccination in clinical trials; September 12,Oxford University and AstraZeneca stated thatAfter investigation,The safety of this vaccine has been recognized by the British Independent Investigation Commission and regulatory agencies.Can resume vaccination for volunteers.After that,Clinical trials in South Africa, Brazil, and the United States have also been approved to resume vaccination.